Last reviewed · How we verify
NCT05474963
Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital
trial in SSNHL(Sudden Sensory Neural Hearing Loss) in 1,000 participants. Currently enrolling.
31 December 2031
Quick facts
| Lead sponsor | Wonju Severance Christian Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 14 July 2021 |
| Primary completion | 31 December 2031 |
| Estimated completion | 31 December 2035 |
| Sites | 1 location across South Korea |
Conditions studied
- SSNHL(Sudden Sensory Neural Hearing Loss) — all drugs for SSNHL(Sudden Sensory Neural Hearing Loss) →
- Sudden Hearing Loss — all drugs for Sudden Hearing Loss →
- Hearing Loss, Idiopathic Sudden Sensorineural — all drugs for Hearing Loss, Idiopathic Sudden Sensorineural →
- Hearing Loss, Sudden — all drugs for Hearing Loss, Sudden →
Sponsor
Wonju Severance Christian Hospital
Who can join
Adults 20 to 100, any sex, with SSNHL(Sudden Sensory Neural Hearing Loss) or Sudden Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to build a cohort of sudden sensorineural hearing loss (SSNHL) patients. When the patient visited the Department of otolaryngology clinic for hearing loss, we can diagnose the SSNHL following the result of pure tone audiometry and the history of the patient. The cohort is a system that tracks the hearing recovery status, timing, and degree of recovery of patients who received cocktail therapy with or without high-dose steroids, vasodilators, antiviral agents, and intratympanic steroid injections, satellite ganglion block, and hyperbaric oxygen therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05474963
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Wonju Severance Christian Hospital trials
Trials by the same sponsor.
- NCT07012499 — QOL and Mental Health Using APD With Remote Monitoring System · NA · enrolling by invitation
- NCT07146178 — Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS · NA · not yet recruiting
- NCT06675396 — Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients · not yet recruiting
- NCT06540430 — Digital Based Home Care Service for Ostomy Patients · NA · not yet recruiting
- NCT07017088 — Efficacy of Leuconostoc Mesenteroides · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05474963 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wonju Severance Christian Hospital
- Last refreshed: 26 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05474963.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing